Double-blind comparative prospective clinical evaluation of a combination antispasmodic--Manyana (R) (diclofenac pitafenone and fenpeverinium) and Baralgan (analgin + pitafenone and fenpeverinium) in intestinal, biliary and ureteric colic.

Chaudhary, AGupta, R L1998-11-282009-05-311998-11-282009-05-311998-11-28Chaudhary A, Gupta RL. Double-blind comparative prospective clinical evaluation of a combination antispasmodic--Manyana (R) (diclofenac pitafenone and fenpeverinium) and Baralgan (analgin + pitafenone and fenpeverinium) in intestinal, biliary and ureteric colic. Journal of the Indian Medical Association. 1998 Nov; 96(11): 359-60http://imsear.searo.who.int/handle/123456789/106057engAdolescentAdultBenzophenones --therapeutic useBiliary Tract Diseases --diagnosisColic --diagnosisDiclofenac --therapeutic useDipyrone --therapeutic useDouble-Blind MethodDrug CombinationsDrug SynergismDrug Therapy, CombinationFemaleHumansIntestinal Diseases --diagnosisMaleMiddle AgedParasympatholytics --therapeutic usePiperidines --therapeutic useProspective StudiesTreatment OutcomeUreteral Diseases --diagnosisDouble-blind comparative prospective clinical evaluation of a combination antispasmodic--Manyana (R) (diclofenac pitafenone and fenpeverinium) and Baralgan (analgin + pitafenone and fenpeverinium) in intestinal, biliary and ureteric colic.Clinical Trial